Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Medtronic
Johnson and Johnson
US Department of Justice
Express Scripts
Colorcon
Federal Trade Commission
Mallinckrodt
Boehringer Ingelheim

Generated: December 16, 2018

DrugPatentWatch Database Preview

Sodium phosphate p-32 - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for sodium phosphate p-32 and what is the scope of sodium phosphate p-32 patent protection?

Sodium phosphate p-32 is the generic ingredient in two branded drugs marketed by Bracco and Mallinckrodt, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are one thousand four hundred and fifty-four drug master file entries for sodium phosphate p-32.

Summary for sodium phosphate p-32

US Patents and Regulatory Information for sodium phosphate p-32

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt SODIUM PHOSPHATE P 32 sodium phosphate p-32 SOLUTION;INJECTION, ORAL 011777-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mallinckrodt SODIUM PHOSPHATE P 32 sodium phosphate p-32 SOLUTION;INJECTION, ORAL 011777-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bracco PHOSPHOTOPE sodium phosphate p-32 SOLUTION;INJECTION, ORAL 010927-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Medtronic
Johnson and Johnson
US Department of Justice
Express Scripts
Colorcon
Federal Trade Commission
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.